$4.74
arrow_drop_up4.86%Key Stats | |
---|---|
Open | $4.71 |
Prev. Close | $4.52 |
EPS | -0.35 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $2.74B |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 4.58 | 4.74 |
52 Week Range | 1.64 | 5.34 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.35 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Tesla Posts Weak Earnings, Joins Visa, Deutsche Bank And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Critical Insights From Geron Analyst Ratings: What You Need To Know
Is Geron Stock a Buy Following Its First New Drug Approval?
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?